Navigation Links
New Venture Funding for Alzheimer's Disease Drug Developer
Date:1/12/2009

MADISON, Wis., Jan. 12 /PRNewswire/ -- Mithridion, Inc., a drug development company focusing on serious Central Nervous System disorders, including Alzheimer's disease (AD), announced today that it held an initial closing of $2.9 million in Series B Preferred Stock financing. The company will use the funds for the clinical development of MCD-386, its lead drug candidate, aimed at stopping or slowing down disease progression and improving memory and cognition in this devastating disorder. The company has raised $7.4 million to date in equity funding.

Venture Investors (VI - Madison, Wis.) led this latest round of financing. The State of Wisconsin Investment Board and Wisconsin Investment Partners, both of Madison, Wis., and Rocket Venture Fund (Toledo. Ohio), all existing shareholders, also participated in the latest funding. Mithridion plans to hold a final closing with respect to this financing on or before March 31, 2009.

John Neis, Managing Director of VI, will join Mithridion's board of directors.

"This new funding will enable Mithridion not only to advance MCD-386 in Phase I trial, but will also support the development of exciting drug leads for AD and schizophrenia in our preclinical pipeline," said Trevor M. Twose, Ph.D., the company's Chief Executive. "We greatly appreciate the continued support of our shareholders," he added.

Five million Americans suffer from Alzheimer's disease today, and the number will grow as baby-boomers age. The market for Alzheimer's disease drugs exceeds $4 billion, but is currently underserved, and may grow to greater than $10 billion with the development of drugs that are more effective.

MCD-386 is highly selective for the M1-type muscarinic receptor. In preclinical laboratory tests, MCD-386 appears to replace deficient brain acetylcholine activity, similar to that caused by AD. This drug is intended to improve memory and cognition
'/>"/>

SOURCE Mithridion, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Foundation Venture Capital Group, LLC Invests in Start Up Committed to Breast Cancer Diagnostics
2. NTU and Insightra Medical Inc. release their first joint venture medical device
3. Amneal Pharmaceuticals & Indoco Remedies Finalize Long Term Joint Venture Agreement to Develop and Market Generic Ophthalmic Pharmaceuticals
4. STAAR Surgical to Purchase Canons Interest in Japanese Joint Venture
5. Harmony Information Systems Raises $28 Million in Series B Financing from JMI Equity, Updata Partners, ORIX Venture Finance and Comerica Bank
6. Venture Health Group Selects Planet DDS Web-based Practice Management Software
7. HLM Venture Partners Leads Series B Financing of CaseNET, Inc.
8. RadPharm Announces $10 million Series B Financing, led by Siemens Venture Capital
9. MM2 Group Establishes New Venture for Sofgel Manufacture in China
10. Radius Ventures Announces Promotion of Dr. David Stoffel to Partner
11. STAAR Surgical Completes $5M Debt Financing for Purchase of Japanese Joint Venture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... Angeles, CA (PRWEB) July 25, 2014 In ... talk about, and eager to reverse the symptoms associated with ... in the media at large, a new case study ... real benefits of testosterone therapy using bioidentical hormones. ... a 38-year-old father from Seattle who found himself beginning to ...
(Date:7/25/2014)... As reported by the New Orleans Advocate ... (7/3), the state of Louisiana has recently seen a ... than cocaine. Officials believe the increase is due to a ... of marijuana. However, both doctors and police confirm that that ... to call it “poison,” doctors have acknowledged that the Louisiana ...
(Date:7/25/2014)... 2014 Sport Court® provided ... Nike National Invitational Tournament (NIT) in Chicago ... Junior National Tournament (USJN) in Washington D.C. at ... for these prestigious national tournaments included 44 Sport Court ... of playing surface at McCormick Place for the NIT, ...
(Date:7/25/2014)... Houston, TX (PRWEB) July 25, 2014 ... Annual Family Fun Fest on Sunday, July 27 at ... franchises include Memorial, Copperfield, Katy, Pearland, Friendswood, Spring, ... location in The Heights. , “We’re thrilled to ... this year,” said Heather Belcher who owns the Sugarland-Missouri ...
(Date:7/25/2014)... July 25, 2014 A new study conducted ... revealed that 39 percent of all children in the survey under ... The survey looked at 2,505 children during the years of 2011 ... years of age. The final result was that about two ... Many of these children were from lower-income families and were of ...
Breaking Medicine News(10 mins):Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 2Health News:New Case Study Highlights Effectiveness of Testosterone Therapy in Fighting Weight Gain and Fatigue 3Health News:Louisiana Recognizes Dangers of Synthetic Marijuana 2Health News:Sport Court Provides All Sports Flooring for Basketball Events in Chicago and Washington D.C. 2Health News:The Little Gym of Houston to Attend Houston Family Magazine’s Family Fun Fest 2014 2Health News:North York Dental Provides Services to Toronto Children in Light of Growing Demand 2Health News:North York Dental Provides Services to Toronto Children in Light of Growing Demand 3
... UCSF institute aimed at accelerating the pace of translating ... million from the National Institutes of Health to expand ... UCSF Clinical and Translational Science Institute (CTSI) is among ... recognition of their successes during the first five years ...
... HealthDay Reporter , MONDAY, July 18 (HealthDay News) -- ... of mild cognitive impairment, a potential precursor of Alzheimer,s ... there may be a very high rate of cognitive ... general population in that age range," said lead researcher ...
... , FRIDAY, July 15 (HealthDay News) -- Although many people ... relationship between stress and alcohol is a two-way street, researchers ... stress, the authors of a new study pointed out. Meanwhile, ... individuals to drink more to produce the same effect. As ...
... (HealthDay News) -- Compared with older people with no signs of ... twice as likely to experience a fall, researchers have found. ... older adults who were participating in a study of memory and ... many times they fell over the course of eight months. ...
... 2011) Today at the 6th International AIDS ... Prevention, the Drugs for Neglected Diseases initiative (DNDi) ... programme to address critical unmet treatment needs of ... in young children has largely been eliminated in ...
... York University,s Department of Chemistry and NYU Langone Medical ... a protein implicated in many types of cancer. The ... journal Nature Chemical Biology. The ... RTK signaling is a major underlying cause of various ...
Cached Medicine News:Health News:UCSF receives $112 million to help translate science into cures 2Health News:UCSF receives $112 million to help translate science into cures 3Health News:UCSF receives $112 million to help translate science into cures 4Health News:Ex-NFL Players May Face Higher Brain Damage Risk, Study Says 2Health News:Ex-NFL Players May Face Higher Brain Damage Risk, Study Says 3Health News:Ex-NFL Players May Face Higher Brain Damage Risk, Study Says 4Health News: Drinking Alcohol May Prolong, Not Relieve, Stress 2Health News:Falls Could Signal Early Alzheimer's Disease 2Health News:DNDi launches new drug development program to address treatment needs of children with HIV/AIDS 2Health News:DNDi launches new drug development program to address treatment needs of children with HIV/AIDS 3
(Date:7/25/2014)... MISSION, Kan. , July 25, 2014 /PRNewswire-iReach/ ... , and TCGRx, of Powers Lake, ... exclusive partners in a distribution and co-marketing agreement ... to retail pharmacies throughout the United ... of robotics-based pharmacy management and workflow systems to ...
(Date:7/25/2014)... GrowBLOX Sciences, Inc. (OTCQB: GBLX) is pleased to ... with LaurelCo, LLC, an Illinois limited ... and dispensary medical marijuana licenses in the state of ... acquire a 20% equity interest in LaurelCo, LLC in exchange ... chambers, as well as all technology related to the machines ...
(Date:7/25/2014)... 25, 2014  Acsis Inc., the market leader ... solutions, has recently posted an article, "Future ... and future needs for companies, extended supply chain, ... chain model no longer work today.  The article ... growth of mobile technology, machine to machine (M2M) ...
Breaking Medicine Technology:ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 2ScriptPro and TCGRx Integrate Pharmacy Automation Technologies 3GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 2GrowBLOX Sciences, Inc. Partners with LaurelCo, LLC to Obtain Licenses to Cultivate and Dispense Medical Marijuana in Illinois 3Acsis Addresses Questions on the Modern Supply Chain 2
... 17 Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) ... Oxygen Concentrate Gel to customers who have pre-ordered through ... today, cover orders received through early November. , "This ... actually shipping a product to customers and generating revenue ...
... , REYKJAVIK, Iceland, Nov. 17 deCODE ... has filed a voluntary petition for relief under Chapter 11 ... Bankruptcy Court for the District of Delaware to facilitate the ... to operate its business and manage its properties as a ...
Cached Medicine Technology:Oxygen Biotherapeutics, Inc. Begins Shipping Cosmetic Product to Customers 2deCODE genetics, Inc. Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets 2deCODE genetics, Inc. Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets 3deCODE genetics, Inc. Files Voluntary Chapter 11 Petition to Facilitate Sale of Assets 4
... integrates drug infusion,with patient monitoring and ... modular platform. With multiple configuration,options, you ... you,need them, keeping the number of ... while managing the unique needs of,each ...
... These specialty Eraser instruments have been ... with the right tool for situations ... a series of 25 gauge intraocular, ... discrete treatment of target tissues for ...
... the first steps any hospital or health ... most powerful, most effective tools available for ... world-class clinician documentation and electronic medical record ... achieve this goal. In fact, its the ...
... instruments have been designed to provide ... tool for situations requiring precise hemostasis. ... 25 gauge intraocular, bipolar, diathermy instruments. ... target tissues for fine-tip hemostasis or ...
Medicine Products: